Image description

Published yearly: 

4 Issues

______________________

ISSN: 2320-964X (Online) 

ISSN: 2320-7817  (Print)

______________________

Editor-in-Chief

Dr. Santosh Pawar 


INDEXED IN

RESEARCH ARTICLE

_______________________________________________________________________________________

Int. Journal of Life Sciences, 2018; 6(3): 755-760       |                 Available online, September 28, 2018

Screening of kojic acid antimicrobial activity against skin pathogens


Ranjit Kumar C* and Jayalakshmi S

 

Center of Advanced study in Marine Biology, Faculty of Marine Sciences, Annamalai University, Parangipettai-608502, Tamilnadu, India

*Corresponding author, email: ranjitaim@gmail.com

 

Received : 11.05.2018    |    Accepted : 24.09.2018       |    Published : 28.09.2018

The antibacterial and antifungal activity of kojic acid was evaluated against medically important skin pathogens. Tube Dilution Assay was used for analyzing of kojic acid minimum inhibitory concentrations (MIC), it was varied from 64 mg/ml to 128 mg/ml. There was no bacterial growth was appeared at MIC 64 mg/ml. Kojic acid inhibited the Trychophyton rubrum MTCC296 and Candidus albicans MTCC3018 growth at MIC 128 mg/ml. Disc diffusion method was chosen to elucidate the antimicrobial activity of the kojic acid.  Kojic acid inhibitory zone observed was 17 mm, 14 mm, 12 mm and 9 mm, respectively against Pseudomonas aeruginosa MTCC1688, Trychophyton rubrum MTCC296, Streptococcus pyogenes MTCC1924, Candidus albicans MTCC3018, respectively.

 

Key words: Kojic acid, Antimicrobial activity, Trichophyton rubrum, Candida albicans, Pseudomonas aeruginosa and Streptococcus pyogenes


_________________________________________________________________________

Editor: Dr.Arvind Chavhan

___________________________________________________________________________________ 

Cite this article as:

Ranjit Kumar C, Jayalakshmi S (2018) Screening of kojic acid antimicrobial activity against skin pathogens, Int. J. of. Life Sciences, Volume 6(3): 755-760. 

____________________________________________________________________________

Acknowledgments

Motivation and financial support provided by my parents (C. Eswaraiah and C. Sumathamma) for carrying out this work is highly acknowledged.

____________________________________________________________________________


Conflicts of interest: The authors stated that no conflicts of interest.

____________________________________________________________________________

 

Copyright: © 2018 | Author(s), This is an open access article under the terms of the Creative Commons Attribution-Non-Commercial - No Derives License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

_________________________________________________________________________

Aytemir MD, Erol DD, Hider RC and Ozalp M (2003) Synthesis and evaluation of       antimicrobial activity of new 3-Hydroxy-6-methyl-4-oxo4H-pyran-2-carboxamide derivatives. Turkish  Journal of Chemtherapy, 27: 757- 764.


Bentley R (2006) From miso, sake and shoyu to cosmetics: a century of science for kojic acid. Natural product Reports, 23: 1046-1062.


Brtko J, Rondahl L, Fickova M, Hudecova D, Eybl V and Uher M (2004) Kojic acid and its derivatives: history and present state of art Central European Journal of Public Health, 12: 16-18.


Carapetis JR, Steer AC, Mulholland EK, and Weber M (2005) "The global burden of group A           streptococcal diseases". The  Lancet Infectious Diseases, 5 (11): 685–94.


Chaudhary J, Pathak ANand Lakhawat S (2014) Production technology and applications of kojic acid. Annual Research and Reviews in Biology, 1;4(21):3165.


Chee HY and Lee EH (2003) Fungistatic activity of kojic acid against human pathogenic fungi and inhibition of melanin production in Cryptococcus neoformans. Mycobiology, 31: 248–250.


Durgadevi KB, Vijayalakshmi P, Shilpa V and Kumar BV (2015) Optimization of cultural parameters for cost effective production of kojic acid by fungal species isolated from soil. Fermentation Technology, 4: 119.


Emami S, Ghafouri E, Faramarzi MA, Samadi N, Irannejad H and Foroumadi A (2013) Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study. European Journal of Medicinal Chemistry, 68: 185-191.


Hassan HM, Saad AM, Hazzaa MM and Ibrahim EI (2014) Optimization Study for the Production of kojic acid crystals by Aspergillus oryzae var. effusus NRC 14 isolate. International Journal of Current Microbiology and Applied Sciences, 3(10): 133-142.


Karaca N and Koç A (2004) In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Diagnostic Microbiology of Infections and Diseases, 48: 259-264.


Kerr KG and Snelling AM (2009) Pseudomonas aeruginosa: a formidable and ever-present adversary. Journal of Hospital Infections, 73: 338-44.


Kim JH, Campbell BC, Chan KL, Mahoney N and Haff RP (2013) Synergism of antifungal activity between mitochondrial respiration inhibitors and kojic acid. Molecules, 18(2): 1564-1581.


Lee FH, Boltjes B and William E (1950) Kojic acid as an inhibitor of tubercle bacilli. American Review of Tuberculosis , 61: 738-741.


Lin MT, Mahajan JR, Dianese JC and Takatsu A (1976) High Production of Kojic acid crystals by Aspergillus parasiticus UNBFA12 in liquid medium. Applied Environmental Microbiology, 32(2): 298-299.


Matar MJ, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E and Rex JH (2003) Correlation between Etest, disk diffusion, and micro dilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrobial Agents and Chemotherapy, 47: 1647 1651.


Morton HE, Kocholaty R, Junowicz K and Kelner A (1945) Toxicity and antibiotic activity of kojic acid produced by Aspergillus luteovirescens. Journal of Bacteriology, 50: 579-584.


National Committee for Clinical Laboratory Standards (NCCLS) (2004) Method for antifungal disk diffusion susceptibility testing of yeasts. National Committee for Clinical Laboratory Standards, Approved guideline M44-A: Wayne, PA.


Niewerth M, Splanemann V, Korting HC, Ring J and Abeck D (1998) Antimicrobial susceptibility testing of dermatophytes comparison of the agar macro dilution and broth micro dilution tests. Journal of Chemotherapy, 44: 31-35.


Nir-Paz R, H Elinav GE Pierard, Walker D, Maly A, Shapiro M, Barton RC , and Polacheck I (2003) Deep infection by Trichophyton rubrum in an immune  compromised patient. Journal of clinical Microbiology, 41:5298 5301.


Ranjit kumar C and Jayalakshmi S (2017) Optimization study for the High Production of Kojic Acid Crystals by Estuarine Aspergillus oryzae RMS2 Isolate. International Journal of Pharmtech Research, 10(1): 550-559.


Rodrigues AP, Carvalho AS, Santos AS, Alves CN, Nascimento JL and Silva EO (2011)   Kojic acid, a secondary metabolite from Aspergillus sp. acts as an inducer of macrophage activation. Cell Biology International, 35: 335–343.


Saito K (1907) über die saurebildungbei Aspergillus oryzae. Journal of Botony, 21:7-11. 

Deutsche.

Santos DA, Barros MES And Hamdan JS (2006) Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. Journal of clinical Microbiology, 44: 98-101.


Yabuta T (1924) The constitution of kojic acid, a δ-pyrone derivative formed by Aspergillus flavus from carbohydrates. Journal of Chemical Society, Transactions, 125: 575-587. 

 

 

 

IJLSCI EVENTS

ADVERTISEMENT

 
















    INTERNATIONAL JOURNAL OF

    LIFE SCIENCES

    Origin & Evolution

    Print ISSN : 2320-7817 

    Online ISSN:2320-964X

    UGC Approved Journal No. 48951


    EDITORIAL OFFICE

    46, Guruwandan, Jawahar Nagar, 

    VMV Road, Amravati- 444604

    Maharashtra, India.

    Tel  + 91- 9970559438  |   9420775527  

    Email: editor@ijlsci.in | editorijlsci@gmail.com